Stimulator of interferon response cGAMP interactor overcomes ERBB2-mediated apatinib resistance in head and neck squamous cell carcinoma
Authors:
Open Access
- 30 August 2021
- journal article
- research article
- Published by Impact Journals, LLC in Aging
- Vol. 13 (16) , 20793-20807
Abstract
Purpose: Apatinib resistance is the main obstacle to the effective treatment of advanced head and neck squamous cell carcinoma (HNSCC). This study aimed to evaluate the function of Erb-B2 receptor tyrosine kinase 2 (ERBB2) and stimulator of interferon response cGAMP interactor (STING) in apatinib resistance in HNSCC.Keywords
This publication has 40 references indexed in Scilit:
- Activation of Stimulator of Interferon Genes in Hepatocytes Suppresses the Replication of Hepatitis B VirusAntimicrobial Agents and Chemotherapy, 2017
- Phase I Study and Biomarker Analysis of Pyrotinib, a Novel Irreversible Pan-ErbB Receptor Tyrosine Kinase Inhibitor, in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast CancerJournal of Clinical Oncology, 2017
- Imaging Cancer Angiogenesis and Metastasis in a Zebrafish Embryo Model2016
- Radiotherapy Combined with Novel STING-Targeting Oligonucleotides Results in Regression of Established TumorsCancer Research, 2016
- Oral Cavity Carcinoma: Current Management, Controversies, and Future DirectionsJournal of Clinical Oncology, 2015
- Pivotal role of vascular endothelial growth factor pathway in tumor angiogenesisAnnals of Surgical Treatment and Research, 2015
- STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic TumorsImmunity, 2014
- Autocrine VEGF Signaling Promotes Proliferation of Neoplastic Barrett's Epithelial Cells Through a PLC-Dependent PathwayGastroenterology, 2014
- Multiple genetic copy number alterations in oral squamous cell carcinoma: study of MYC , TP53 , CCDN1, EGFR and ERBB2 status in primary and metastatic tumoursBritish Journal of Dermatology, 2010
- Role of angiogenesis in tumor growth and metastasisSeminars in Oncology, 2002